Edition:
United States

VIVUS Inc (VVUS.OQ)

VVUS.OQ on NASDAQ Stock Exchange Global Select Market

1.05USD
10:54am EDT
Change (% chg)

$0.02 (+1.94%)
Prev Close
$1.03
Open
$1.02
Day's High
$1.05
Day's Low
$1.02
Volume
13,943
Avg. Vol
79,169
52-wk High
$1.75
52-wk Low
$0.94

Select another date:

Mon, Mar 27 2017

BRIEF-Vivus reacquires Stendra(R)(AVANAFIL)commercial rights from Sanofi

* Reacquires Stendra(R) (Avanafil) commercial rights from Sanofi

BRIEF-Vivus entered into settlement agreement with Hetero on Jan. 3

* On Jan 3, co entered into a settlement agreement with hetero - sec filing

BRIEF-Vivus and Selten Pharma announce agreement for development and commercialization rights to treatments for PAH

* Vivus and Selten Pharma announce agreement for the development and commercialization rights to treatments for Pulmonary Arterial Hypertension (PAH)

BRIEF-Vivus reports Q3 net loss per share $0.09

* Qtrly total revenue $13.4 million versus $24.9 million Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web